A detailed history of Ubs Group Ag transactions in Anika Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 7,089 shares of ANIK stock, worth $173,822. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,089
Previous 18,729 62.15%
Holding current value
$173,822
Previous $475,000 62.32%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$24.57 - $28.47 $285,994 - $331,390
-11,640 Reduced 62.15%
7,089 $179,000
Q1 2024

May 13, 2024

BUY
$21.95 - $26.42 $74,256 - $89,378
3,383 Added 22.04%
18,729 $475,000
Q4 2023

Feb 09, 2024

BUY
$18.47 - $23.3 $110,265 - $139,101
5,970 Added 63.67%
15,346 $347,000
Q3 2023

Nov 09, 2023

SELL
$16.98 - $26.1 $237,091 - $364,434
-13,963 Reduced 59.83%
9,376 $174,000
Q2 2023

Aug 11, 2023

BUY
$25.16 - $28.86 $85,367 - $97,921
3,393 Added 17.01%
23,339 $606,000
Q1 2023

May 12, 2023

SELL
$25.91 - $32.1 $128,617 - $159,344
-4,964 Reduced 19.93%
19,946 $572,000
Q4 2022

Feb 08, 2023

BUY
$23.85 - $31.91 $456,226 - $610,406
19,129 Added 330.89%
24,910 $737,000
Q3 2022

Nov 10, 2022

BUY
$21.74 - $24.68 $17,935 - $20,361
825 Added 16.65%
5,781 $137,000
Q2 2022

Aug 10, 2022

SELL
$20.4 - $25.53 $493,822 - $618,004
-24,207 Reduced 83.01%
4,956 $110,000
Q1 2022

May 16, 2022

SELL
$24.7 - $36.54 $15,141 - $22,399
-613 Reduced 2.06%
29,163 $732,000
Q4 2021

Feb 14, 2022

BUY
$35.83 - $45.03 $334,616 - $420,535
9,339 Added 45.7%
29,776 $1.07 Million
Q3 2021

Nov 15, 2021

BUY
$38.75 - $44.47 $399,977 - $459,019
10,322 Added 102.05%
20,437 $870,000
Q2 2021

Aug 13, 2021

SELL
$39.42 - $48.08 $372,519 - $454,356
-9,450 Reduced 48.3%
10,115 $438,000
Q1 2021

May 12, 2021

BUY
$32.49 - $45.96 $603,631 - $853,890
18,579 Added 1884.28%
19,565 $798,000
Q4 2020

Feb 11, 2021

SELL
$32.59 - $45.26 $36,728 - $51,008
-1,127 Reduced 53.34%
986 $45,000
Q3 2020

Nov 12, 2020

BUY
$32.56 - $38.57 $30,541 - $36,178
938 Added 79.83%
2,113 $75,000
Q2 2020

Jul 31, 2020

SELL
$27.83 - $37.73 $159,772 - $216,607
-5,741 Reduced 83.01%
1,175 $44,000
Q1 2020

May 01, 2020

BUY
$22.38 - $54.06 $70,631 - $170,613
3,156 Added 83.94%
6,916 $200,000
Q4 2019

Feb 14, 2020

SELL
$51.85 - $73.36 $1.74 Million - $2.46 Million
-33,524 Reduced 89.92%
3,760 $195,000
Q3 2019

Nov 14, 2019

BUY
$40.05 - $57.47 $757,305 - $1.09 Million
18,909 Added 102.91%
37,284 $2.05 Million
Q2 2019

Aug 14, 2019

SELL
$30.3 - $41.14 $2.75 Million - $3.73 Million
-90,757 Reduced 83.16%
18,375 $747,000
Q1 2019

May 14, 2019

BUY
$29.37 - $40.49 $1.11 Million - $1.52 Million
37,662 Added 52.7%
109,132 $3.3 Million
Q4 2018

Feb 14, 2019

BUY
$30.16 - $43.0 $259,858 - $370,488
8,616 Added 13.71%
71,470 $2.4 Million
Q3 2018

Nov 14, 2018

BUY
$32.83 - $42.51 $352,430 - $456,344
10,735 Added 20.6%
62,854 $2.65 Million
Q2 2018

Aug 14, 2018

BUY
$28.77 - $48.27 $1.41 Million - $2.37 Million
49,026 Added 1585.06%
52,119 $1.67 Million
Q1 2018

May 15, 2018

SELL
$49.22 - $68.43 $81,705 - $113,593
-1,660 Reduced 34.93%
3,093 $154,000
Q4 2017

Feb 14, 2018

BUY
$52.14 - $59.94 $114,134 - $131,208
2,189 Added 85.37%
4,753 $256,000
Q3 2017

Nov 14, 2017

BUY
$51.16 - $58.21 $38,728 - $44,064
757 Added 41.89%
2,564 $148,000
Q2 2017

Aug 14, 2017

BUY
N/A
86 Added 5.0%
1,807 $89,000
Q1 2017

Nov 14, 2017

BUY
N/A
1,721
1,721 $75,000

About Anika Therapeutics, Inc.


  • Ticker ANIK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,599,900
  • Market Cap $358M
  • Description
  • Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactur...
More about ANIK
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.